K. Rassnick

发表

Retrospective study of orthovoltage radiation therapy for nasal tumors in 42 dogs.

W. Rand, N. Northrup, S. Etue, 2001 .

Cross-sectional study to investigate the association between vitamin D status and cutaneous mast cell tumours in Labrador retrievers.

D. Trump, J. Wakshlag, K. Rassnick, 2011, The British journal of nutrition.

Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).

H. Erb, N. Northrup, K. Selting, 2011, Journal of the American Veterinary Medical Association.

Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).

L. Williams, R. Al-Sarraf, K. Rassnick, 2008, Journal of the American Veterinary Medical Association.

Phase I evaluation of carboplatin by use of a dosing strategy based on a targeted area under the platinum concentration-versus-time curve and individual glomerular filtration rate in cats with tumors.

L. Pendyala, N. Dykes, K. Rassnick, 2009, American journal of veterinary research.

Hepatotoxicity Associated with CCNU (Lomustine) Chemotherapy in Dogs

N. Northrup, A. Moore, S. Cotter, 2004 .

Outcome of cats with low-grade lymphocytic lymphoma: 41 cases (1995-2005).

H. Erb, S. McDonough, K. Simpson, 2008, Journal of the American Veterinary Medical Association.

Relation of Vitamin D Status to Congestive Heart Failure and Cardiovascular Events in Dogs

K. Refsal, J. Wakshlag, M. Kraus, 2013, Journal of veterinary internal medicine.

Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumours.

D. Trump, J. Wakshlag, D. Russell, 2010, Veterinary and comparative oncology.

Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993-2003).

H. Erb, T. Gieger, B. Njaa, 2006, Journal of the American Veterinary Medical Association.

A combination chemotherapy protocol with dose intensification and autologous bone marrow transplant (VELCAP-HDC) for canine lymphoma.

P. Quesenberry, A. Moore, A. Frimberger, 2006, Journal of veterinary internal medicine.

Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989-1999).

G. Ogilvie, R. Nelson, C. Henry, 2002, Journal of the American Veterinary Medical Association.

Carboplatin for treatment of a Sertoli cell tumor in a mallard (Anas platyrhynchos).

A. Alcaraz, S. Childs-Sanford, K. Rassnick, 2006, Veterinary and comparative oncology.

Phase I and pharmacokinetic evaluation of the combination of orally administered docetaxel and cyclosporin A in tumor-bearing dogs.

R. Page, L. Lewis, M. Mcentee, 2006, American journal of veterinary research.

An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours.

H. Erb, S. McDonough, D. Russell, 2010, Journal of comparative pathology.

Enhanced bioavailability of oral docetaxel by co-administration of cyclosporin A in dogs and rats.

R. Page, M. Mcentee, J. Silverman, 2003, Veterinary and comparative oncology.

Effect of glomerular filtration rate on clearance and myelotoxicity of carboplatin in cats with tumors.

P. J. Hoopes, H. Erb, R. Page, 2004, American journal of veterinary research.

Phase I dose escalation of single-agent vinblastine in dogs.

K. Rassnick, C. Balkman, J. Chretin, 2008, Journal of veterinary internal medicine.

Oral bioavailability of etoposide after administration of a single dose to tumor-bearing dogs.

L. Lewis, M. Kiselow, K. Rassnick, 2008, American journal of veterinary research.

Retrospective study of orthovoltage radiation therapy for nasal tumors in 42 dogs.

N. Northrup, S. Etue, A. Moore, 2001, Journal of veterinary internal medicine.

Cyclooxygenase-2 Immunoreactivity in Equine Ocular Squamous-Cell Carcinoma

B. Njaa, K. Rassnick, 2007, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

Disseminated canine herpesvirus-1 infection in an immunocompromised adult dog.

E. Ledbetter, D. Russell, S. G. Kim, 2010, Journal of veterinary internal medicine.

Outcome of 19 dogs with parathyroid carcinoma after surgical excision.

C. Schmiedt, N. Northrup, E. Sawyer, 2012, Veterinary and comparative oncology.

Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989-2000).

R. M. Gamblin, D. Bruyette, A. Moore, 2001, Journal of the American Veterinary Medical Association.

MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000).

G. Mauldin, A. Moore, G. Mauldin, 2002, Journal of veterinary internal medicine.

MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000)

G. Mauldin, A. Moore, G. Mauldin, 2002 .

Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.

B. Kitchell, N. Northrup, M. Kleiter, 2014, Veterinary and comparative oncology.

Ureteral mast cell tumor in a dog.

B. Porter, B. Njaa, K. Rassnick, 2004, The Journal of the American Animal Hospital Association.

Evaluation of serum iohexol clearance for use in predicting carboplatin clearance in cats.

N. Dykes, K. Rassnick, D. Bailey, 2009, American journal of veterinary research.

In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors

Wei-dong Yu, D. Trump, Candace S. Johnson, 2008, Cancer Chemotherapy and Pharmacology.

Treatment of canine mast cell tumors with CCNU (lomustine).

C. London, A. Moore, L. Williams, 1999, Journal of veterinary internal medicine.

Medical management of soft tissue sarcomas.

K. Rassnick, 2003, The Veterinary clinics of North America. Small animal practice.

Phase I dose escalating study of oral cyclophosphamide in tumour-bearing cats.

A. Moore, A. Frimberger, K. Rassnick, 2020, Veterinary journal.

CCNU in the treatment of canine epitheliotropic lymphoma.

S. Lana, K. Hansen, L. Williams, 2006, Journal of veterinary internal medicine.

A case of multiple epitrichial sweat gland ductal carcinomas in a horse.

T. Divers, D. Scott, A. L. Johnson, 2007, Veterinary dermatology.

Palliation of clinical signs in 48 dogs with nasal carcinomas treated with coarse-fraction radiation therapy.

P. Bergman, Annette N Smith, N. Northrup, 2008, Journal of the American Animal Hospital Association.

Results of a phase II clinical trial on the use of ifosfamide for treatment of cats with vaccine-associated sarcomas.

C. Rodriguez, C. Khanna, R. Page, 2006, American journal of veterinary research.

A. Gruber, J. Cullen, M. Miller, 2011, Veterinary pathology.

A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.

D. Russell, M. Kiselow, K. Rassnick, 2010, Veterinary and comparative oncology.

Efficacy of vinblastine for treatment of canine mast cell tumors.

M. Kiselow, K. Rassnick, A. Flory, 2008, Journal of veterinary internal medicine.

Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990-2001).

N. Northrup, J. Scarlett, T. Gieger, 2005, Journal of the American Veterinary Medical Association.

Orthovoltage radiation and weekly low dose of doxorubicin for the treatment of incompletely excised soft-tissue sarcomas in 39 dogs

A. Moore, N. King, A. Frimberger, 2007, Veterinary Record.

An Immunohistochemical Study of Cyclooxygenase-2 Expression in Various Feline Neoplasms

S. McDonough, A. Moore, K. Rassnick, 2003, Veterinary pathology.

Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.

N. Northrup, A. Moore, K. Rassnick, 2009, Journal of veterinary internal medicine.

Efficacy o f Combination C hemotherapy f or Treatment o f Gastrointestinal L ymphoma i n D ogs

K. Rassnick, O. Kristal, 2009 .

Clinical characteristics, treatment, and outcome of dogs with presumed primary hepatic lymphoma: 18 cases (1992-2008).

C. Rodriguez, T. Gieger, G. Segev, 2011, Journal of the American Veterinary Medical Association.

Prognostic value of argyrophilic nucleolar organizer region (AgNOR) staining in feline intestinal lymphoma.

S. Moroff, G. Mauldin, M. Mcentee, 1999, Journal of veterinary internal medicine.

Neutropenia associated with vincristine and L-asparaginase induction chemotherapy for canine lymphoma.

N. Northrup, A. Moore, S. Cotter, 2002, Journal of veterinary internal medicine.

Long-term control of mucocutaneous squamous cell carcinoma and metastases in a horse using piroxicam.

A. Moore, K. Rassnick, S. L. Beam, 2010, Equine veterinary journal.

Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.

L. L. Barlow, M. Kiselow, K. Rassnick, 2010, Veterinary and comparative oncology.

Use of a vascular access system for administration of chemotherapeutic agents to a ferret with lymphoma.

J. Flanders, K. Rassnick, W. J. Gould, 1995, Journal of the American Veterinary Medical Association.

Immunohistochemical Characterization of Feline Mast Cell Tumors

C. Rodriguez, N. Northrup, T. Gieger, 2013, Veterinary pathology.

Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs.

R. Al-Sarraf, K. Rassnick, J. Chretin, 2010, Veterinary and comparative oncology.

Use of vascular access ports with intrathoracic drains for treatment of pleural effusion in three dogs.

J. Flanders, A. K. Cahalane, K. Rassnick, 2007, Journal of the American Veterinary Medical Association.

Biological behaviour of canine mandibular osteosarcoma. A retrospective study of 50 cases (1999-2007).

C. Rodriguez, T. Fan, N. Northrup, 2015, Veterinary and comparative oncology.

Prophylactic trimethoprim-sulfadiazine during chemotherapy in dogs with lymphoma and osteosarcoma: a double-blind, placebo-controlled study.

G. Ogilvie, N. Shaw, N. Northrup, 2007, Journal of veterinary internal medicine.

Treatment of vascular and soft-tissue sarcomas in dogs using an alternating protocol of ifosfamide and doxorubicin.

N. Northrup, A. Moore, A. Frimberger, 2003, Veterinary and comparative oncology.

Stage migration in dogs with lymphoma.

H. Erb, T. Stokol, P. Scrivani, 2007, Journal of veterinary internal medicine.

Outcomes of cats with oral tumors treated with mandibulectomy: 42 cases.

N. Northrup, K. Cornell, T. Gieger, 2006, Journal of the American Animal Hospital Association.

Prospective evaluation of biweekly streptozotocin in 19 dogs with insulinoma.

N. Northrup, T. Gieger, M. Rosenberg, 2013, Journal of veterinary internal medicine.

Chemotherapy during pregnancy: a review of the literature.

S. J. Bedford-Guaus, K. Rassnick, K. Autio, 2007, Veterinary and comparative oncology.

Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma.

N. Northrup, A. Moore, D. Russell, 2010, Journal of veterinary internal medicine.

Use of a centrifugation-based, point-of-care device for production of canine autologous bone marrow and platelet concentrates.

R. Todhunter, W. Berg-Foels, T. Stokol, 2006, American journal of veterinary research.

Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs.

R. Al-Sarraf, M. Kiselow, K. Rassnick, 2008, Journal of veterinary internal medicine.

A combination chemotherapy protocol with MOPP and CCNU consolidation (Tufts VELCAP-SC) for the treatment of canine lymphoma.

N. Northrup, A. Moore, L. Williams, 2003, Veterinary and comparative oncology.

Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma.

H. Erb, Hollis N Erb, M. Mcentee, 2007, Journal of veterinary internal medicine.

Evaluation of ifosfamide for treatment of various canine neoplasms.

A. Moore, L. Williams, A. Frimberger, 2000, Journal of veterinary internal medicine.

Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma.

M. Kiselow, K. Rassnick, E. Malone, 2014, Journal of the American Animal Hospital Association.

Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs.

N. Northrup, A. Moore, S. Cotter, 2004, Journal of veterinary internal medicine.

Phase I trial and pharmacokinetic analysis of ifosfamide in cats with sarcomas.

R. Page, N. Northrup, L. Lewis, 2006, American journal of veterinary research.

Evaluation of dexamethasone as a chemoprotectant for CCNU-induced bone marrow suppression in dogs.

J. Wakshlag, R. Al-Sarraf, M. Kiselow, 2009, Veterinary and comparative oncology.

Survival time for dogs with previously untreated, peripheral nodal, intermediate- or large-cell lymphoma treated with prednisone alone: the Canine Lymphoma Steroid Only trial.

D. Kamstock, Margaret L. Musser, M. Kiselow, 2021, Journal of the American Veterinary Medical Association.

Evaluation of anti-human leukocyte antigen-DR monoclonal antibody therapy in spontaneous canine lymphoma

D. Goldenberg, R. Page, R. Stein, 2011, Leukemia & lymphoma.

A prospective evaluation of the impact of second-opinion histopathology on diagnostic testing, cost and treatment in dogs and cats with cancer.

S. McDonough, K. Rassnick, E. Malone, 2015, Veterinary and comparative oncology.

Comparison of first-opinion and second-opinion histopathology from dogs and cats with cancer: 430 cases (2001-2008).

S. McDonough, K. Rassnick, C. Balkman, 2010, Veterinary and comparative oncology.

Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011-2014).

A. Moore, A. Frimberger, K. Rassnick, 2017, Journal of the American Veterinary Medical Association.

A Combination Chemotherapy Protocol with Dose Intensification and Autologous Bone Marrow Transplant (VELCAP‐HDC) for Canine Lymphoma

P. Quesenberry, A. Moore, A. Frimberger, 2006 .

Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001).

M. Mcentee, T. Gieger, H. Decock, 2003, Journal of veterinary internal medicine.

Retrospective evaluation of COX‐2 expression, histological and clinical factors as prognostic indicators in dogs with renal cell carcinomas undergoing nephrectomy†

P. Buracco, M. Atherton, S. Priestnall, 2017, Veterinary and comparative oncology.

Microalbuminuria is not associated with cisplatin-induced azotemia in dogs.

H. Erb, R. Goldstein, K. Rassnick, 2007, Journal of veterinary internal medicine.

Phase I I, O pen-Label T rial of Single-Agent C CNU in Dogs w ith Previously Untreated H istiocytic S arcoma

K. Rassnick, O. Kristal, 2010 .

Use of vascular access ports in femoral veins of dogs and cats with cancer.

J. Flanders, A. K. Cahalane, K. Rassnick, 2007, Journal of the American Veterinary Medical Association.

Oral bioavailability of DN101, a concentrated formulation of calcitriol, in tumor-bearing dogs

D. Trump, Candace S. Johnson, K. Rassnick, 2010, Cancer Chemotherapy and Pharmacology.

Retrospective evaluation of clinical outcome after chemotherapy for lymphoma in 15 equids (1991‐2017)

D. Bedenice, A. Frimberger, D. Luethy, 2019, Journal of veterinary internal medicine.

Phase I evaluation of CCNU (lomustine) in tumor-bearing cats.

N. Northrup, A. Moore, T. Gieger, 2001, Journal of veterinary internal medicine.

Toxicology of Antineoplastic Treatments

K. Rassnick, 2020 .

Specimens in Veterinary Surgical Pathology Recommended Guidelines for Submission, Trimming, Margin Evaluation, and Reporting of Tumor Biopsy

A. Gruber, J. Cullen, M. Kiupel, 2011 .

Treatment of vascular and soft-tissue sarcomas in dogs using an alternating protocol of ifosfamide and doxorubicin.

N. Northrup, A. Frimberger, K. Rassnick, 2003, Veterinary and Comparative Oncology.

Phase I dose escalation of single-agent vinblastine in dogs.

K. Rassnick, C. Balkman, J. Chretin, 2008, Journal of veterinary internal medicine.

Enhanced bioavailability of oral docetaxel by co-administration of cyclosporin A in dogs and rats.

M. Mcentee, J. Silverman, K. Rassnick, 2003, Veterinary and comparative oncology.

Comparison of two questionnaires to assess gastrointestinal toxicity in dogs and cats treated with chemotherapy*.

M. Kiselow, K. Rassnick, E. Malone, 2011, Veterinary and comparative oncology.

Oral bioavailability of etoposide after administration of a single dose to tumor-bearing dogs.

L. Lewis, M. Kiselow, K. Rassnick, 2008, American journal of veterinary research.

adju-Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011–2014)

A. Frimberger, K. Rassnick, Antony S. Moore, 2022 .